Sanofi collaborates to develop novel mRNA vaccine candidate against COVID-19
Pharmaceutical company Sanofi will collaborate with
clinical-stage messenger RNA therapeutics company to develop a novel mRNA
vaccine for COVID-19. This will be Sanofi's second collaboration in the effort
to develop a novel COVID-19 vaccine candidate. Their vaccine expertise from
external research networks will assist in advancing vaccine candidates for
potential further development. Translate Bio is producing multiple mRNA
constructs and will use their mRNA platform to discover, design and manufacture
a number of SARS-CoV-2 vaccine candidates.
What do you think?
You must be
to post a comment.